Get the Stockscreener App
1.72
1.15%
-0.02
Climb Bio Inc stock is traded at $1.72, with a volume of 182.81K.
It is down -1.15% in the last 24 hours and down -8.51% over the past month.
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.
See More
Previous Close:
$1.74
Open:
$1.73
24h Volume:
182.81K
Relative Volume:
0.31
Market Cap:
$117.28M
Revenue:
-
Net Income/Loss:
$-64.20M
P/E Ratio:
-0.80
EPS:
-2.15
Net Cash Flow:
$57,000
1W Performance:
-6.52%
1M Performance:
-8.51%
6M Performance:
+33.33%
1Y Performance:
-44.34%
1-Day Range:
$1.71
$1.77
1-Week Range:
$1.635
$1.9156
52-Week Range:
$1.05
$3.21
Climb Bio Inc Stock (CLYM) Company Profile
Name
Climb Bio Inc
Sector
Industry
Phone
1-866-857-2596
Address
20 WILLIAM STREET, WELLESLEY HILLS
Compare CLYM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLYM
Climb Bio Inc
|
1.72 | 118.64M | 0 | -64.20M | 57,000 | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Climb Bio Inc Stock (CLYM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-16-25 | Initiated | William Blair | Outperform |
| Oct-13-25 | Initiated | H.C. Wainwright | Buy |
| Aug-15-25 | Initiated | Robert W. Baird | Outperform |
| Jun-06-25 | Initiated | Oppenheimer | Outperform |
| May-22-25 | Initiated | BTIG Research | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
View All
Climb Bio Inc Stock (CLYM) Latest News
Stocks of Korro Bio Inc (KRRO) are poised to climb above their peers - Setenews
Stocks of Upstream Bio Inc (UPB) are poised to climb above their peers - Setenews
Can Climb Bio Inc. stock withstand economic slowdown2025 Dividend Review & Risk Managed Investment Strategies - Newser
Is Climb Bio Inc. stock a safe investment in uncertain marketsTrade Entry Report & Low Risk Investment Opportunities - BỘ NỘI VỤ
Climb Bio, Inc. (CLYM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Climb Bio reports inducement grant under Nasdaq listing rule - MSN
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - markets.businessinsider.com
Brokerages Set Climb Bio, Inc. (NASDAQ:CLYM) Price Target at $9.20 - Defense World
Climb Bio (Nasdaq: CLYM) Announces Inducement Option for 120K Shares - Stock Titan
Climb Bio Inc (CLYM) Performance and Fundamentals Dashboard tells a completely different story - Setenews
Published on: 2025-11-19 22:13:39 - newser.com
Is Climb Bio Inc. stock a buy on dipsMarket Activity Summary & Low Risk High Win Rate Stock Picks - newser.com
How sustainable is Climb Bio Inc. stock dividend payoutWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com
Is Climb Bio Inc. stock attractive after correctionQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
Why Climb Bio Inc. stock is recommended by analystsInsider Selling & Accurate Buy Signal Alerts - newser.com
Predicting Climb Bio Inc. trend using moving averages2025 Top Gainers & Reliable Price Breakout Signals - newser.com
Strategies to average down on Climb Bio Inc.2025 Big Picture & Capital Efficiency Focused Ideas - newser.com
Will Climb Bio Inc. stock go up soonRate Cut & High Win Rate Trade Tips - newser.com
Visualizing Climb Bio Inc. stock with heatmapsForecast Cut & Stock Market Timing Techniques - newser.com
Momentum divergence signals in Climb Bio Inc. chart2025 Risk Factors & Free Safe Entry Trade Signal Reports - newser.com
Has Climb Bio Inc. formed a bullish divergence2025 Price Targets & Safe Entry Trade Signal Reports - newser.com
Using R and stats models for Climb Bio Inc. forecastingJuly 2025 Chart Watch & Free High Return Stock Watch Alerts - newser.com
Climb Bio, Inc. Reports Q3 2025 Financial Results - MSN
Analysts Offer Insights on Healthcare Companies: Climb Bio (CLYM) and Vertex Pharmaceuticals (VRTX) - The Globe and Mail
What institutional flow reveals about Climb Bio Inc.Long Setup & Consistent Income Trade Ideas - newser.com
Is Climb Bio Inc (CLYM) positioned for future growth? - Setenews
Applied Therapeutics Inc (APLT) expanding its growth trajectory ahead - setenews.com
Climb Bio Inc Stock (CLYM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):